Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results
BERKELEY HEIGHTS, N.J., May 05, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure
SAN CARLOS, Calif., May 05, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions […]
RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine
Talicia® is approved by the U.S. FDA and promoted by RedHill’s U.S. sales force—Abstract discussing Talicia pharmacokinetics and exposure-response presented […]
XENLETA® (Lefamulin) Treatment Results in a Rapid Time-to-Clinical Response in Hospitalized Patients with Community-Acquired Bacterial Pneumonia (CABP)
DUBLIN, Ireland, May 05, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]
R1 RCM Reports First Quarter 2020 Results
CHICAGO, May 05, 2020 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management […]
CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap
SOUTH SAN FRANCISCO, Calif., May 05, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
Baudax Bio Announces Presentation of New Phase IIIb ANJESO™ Data at Digestive Disease Week 2020
MALVERN, Pa., May 05, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]
Harvard Bioscience Announces First Quarter 2020 Financial Results
HOLLISTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for […]
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) — Codexis, Inc., a leading protein engineering company and developer of novel […]
Oxford Immunotec Reports First Quarter 2020 Financial Results
First quarter revenue of $13.9 million, a decrease of 6% compared to prior year period, due to the impact of […]
